Huntsman Announces Fourth Quarter and Full Year 2020 Earnings; Strong Recovery with Solid Cash Flow

Loading...
Loading...

THE WOODLANDS, Texas, Feb. 12, 2021 /PRNewswire/ --

Fourth Quarter Highlights

  • Fourth quarter 2020 net income of $360 million compared to net income of $308 million in the prior year period; fourth quarter 2020 diluted earnings per share of $1.54 compared to diluted earnings per share of $1.34 in the prior year period.
  • Fourth quarter 2020 adjusted net income of $113 million compared to adjusted net income of $65 million in the prior year period; fourth quarter 2020 adjusted diluted earnings per share of $0.51 compared to adjusted diluted earnings per share of $0.29 in the prior year period.
  • Fourth quarter 2020 adjusted EBITDA of $240 million compared to adjusted EBITDA of $182 million in the prior year period.
  • Fourth quarter 2020 net cash provided by operating activities from continuing operations was $167 million. Free cash flow from continuing operations was $88 million for the fourth quarter 2020 and adjusted free cash flow from continuing operations was $157 million.
  • Balance sheet remains strong with a net leverage of 0.8x and total liquidity is approximately $3 billion. On January 15, 2021 we redeemed in full €445 million (approximately $541 million) in aggregate principle amount of our 5.125% Senior notes due 2021 at par from available cash.
  • Completed the sale of Venator Materials PLC ordinary shares to funds advised by SK Capital on December 23, 2020. Together with estimated cash tax savings of approximately $150 million, which this transaction facilitated, secured an aggregate total cash benefit of approximately $250 million.
  • Announced the acquisition of Gabriel Performance Products within our Advanced Materials segment for $250 million on December 7, 2020, which was completed on January 15, 2021.
  • In our Company wide optimization efforts, we are now targeting annualized savings and acquisition integration synergies in excess of $120 million, to be achieved by mid-2023. $27 million of targeted annualized savings achieved in 2020.

 













Three months ended


Twelve months ended




December 31,


December 31,


In millions, except per share amounts


2020


2019


2020


2019












Revenues


$     1,668


$     1,657


$     6,018


$     6,797












Net income


$        360


$        308


$     1,066


$        598


Adjusted net income(1)


$        113


$          65


$        218


$        353












Diluted income per share


$       1.54


$       1.34


$       4.66


$       2.44


Adjusted diluted income per share(1)


$       0.51


$       0.29


$       0.98


$       1.53












Adjusted EBITDA(1)


$        240


$        182


$        647


$        846












Net cash provided by operating activities from continuing operations


$        167


$        222


$        277


$        656


Free cash flow from continuing operations(2)


$          88


$        129


$          28


$        382


Adjusted free cash flow from continuing operations(6)


$        157


$        129


$        285


$        382












See end of press release for footnote explanations and reconciliations of non-GAAP measures.








Huntsman Corporation HUN today reported fourth quarter 2020 results with revenues of $1,668 million, net income of $360 million, adjusted net income of $113 million and adjusted EBITDA of $240 million

Peter R. Huntsman, Chairman, President and CEO, commented:

"In the midst of a very challenging 2020, our commitment was to emerge stronger and better.  I am very pleased to report that we were able to exceed our expectations. Our fourth quarter adjusted EBITDA significantly exceeded our fourth quarter of a year ago, even despite a lagging recovery in Aerospace.  We also delivered a solid fourth quarter and full year free cash flow, beyond what we anticipated. We had added three highly complementary, differentiated businesses to our core portfolio, and are on track to deliver on over $40 million of annualized related synergies. Together with our cost realignment and business optimization plans, we target in excess of $120 million of annualized benefits by mid-2023.  Our balance sheet remains very strong.  While we are prepared for macro uncertainties to continue in 2021, we see steady improvements over 2020 in most of our core markets and we remain totally committed to creating value for our shareholders."   

Segment Analysis for 4Q20 Compared to 4Q19

Polyurethanes

The increase in revenues in our Polyurethanes segment for the three months ended December 31, 2020 compared to the same period in 2019 was primarily due to higher MDI average selling prices, partially offset by lower sales volumes.  Both differentiated and component MDI average selling prices increased primarily in China and Europe.  MDI sales volumes decreased primarily due to unplanned supplier outages.  The increase in segment adjusted EBITDA was primarily due to higher MDI margins driven by higher MDI pricing, partially offset by lower MDI sales volumes. 

Performance Products

The decrease in revenues in our Performance Products segment for the three months ended December 31, 2020 compared to the same period in 2019 was primarily due to lower sales volumes and average selling prices.  Sales volumes and average selling prices decreased largely due to weakened market conditions across several of our amines businesses.  The slight decrease in adjusted EBITDA is due to the lower sales volumes and average selling prices partially offset by lower fixed costs.

Advanced Materials

The decrease in revenues in our Advanced Materials segment for the three months ended December 31, 2020 compared to the same period in 2019 was primarily due to lower sales volumes, predominantly due to weakness in our aerospace and commodity markets. Sales volumes decreased across most markets primarily due to economic slowdown and customer destocking. Segment adjusted EBITDA decreased due to lower sales volumes, partially offset by lower fixed costs.  The adjusted EBITDA contribution from our recent acquisition of CVC Thermoset Specialties was offset by the lost adjusted EBITDA from the divestiture of our India-based DIY consumer adhesives business.   

Textile Effects

The decrease in revenues in our Textile Effects segment for the three months ended December 31, 2020 compared to the same period in 2019 was due to lower average selling price, partially offset by higher sales volumes.  Average selling prices decreased primarily from market-adjusted pricing aligned to raw material costs.  Sales volumes increased mainly in the Asia region.  Segment adjusted EBITDA was flat with the lower sales revenue being offset by lower raw material costs and lower fixed costs.

Corporate, LIFO and other

For the three months ended December 31, 2020, adjusted EBITDA from Corporate and other for Huntsman Corporation decreased by $4 million to a loss of $47 million from a loss of $43 million for the same period of 2019.

Liquidity and Capital Resources

During the three months ended December 31, 2020, our adjusted free cash flow from continuing operations was $157 million as compared to $129 million in the prior year period.  As of December 31, 2020, we had approximately $3 billion of combined cash and unused borrowing capacity.

During the three months ended December 31, 2020, we spent $79 million on capital expenditures as compared to $93 million in the same period of 2019.  For the year ended December 31, 2020 we spent $249 million on capital expenditures.  For 2021 we expect to spend between $320 million to $330 million on capital expenditures.

Income Taxes

In the fourth quarter 2020, our adjusted effective tax rate was 17%.  For 2021, our adjusted effective tax rate is expected to be approximately 22% - 24%. 

Earnings Conference Call Information

We will hold a conference call to discuss our fourth quarter 2020 financial results on Friday, February 12, 2021 at 10:00 a.m. ET.

Loading...
Loading...

Webcast link: https://78449.themediaframe.com/dataconf/productusers/hun/mediaframe/42984/indexl.html

Participant dial-in numbers:


Domestic callers:    

(877) 402-8037

International callers:

(201) 378-4913

The conference call will be accompanied by presentation slides that will be accessible via the webcast link and Huntsman's investor relations website, ir.huntsman.com.  Upon conclusion of the call, the webcast replay will be accessible via Huntsman's website.

Upcoming Conferences
During the first quarter 2021, a member of management is expected to present at:
Alembic Global Advisors Virtual Deer Valley Chemical Conference on February 25, 2021
Bank of America Agriculture and Materials Virtual Conference on March 3, 2021

A webcast of the presentation, if applicable, along with accompanying materials will be available at ir.huntsman.com.

 

Table 1 – Results of Operations













Three months ended


Twelve months ended




December 31,


December 31,


In millions, except per share amounts


2020


2019


2020


2019












Revenues


$     1,668


$     1,657


$     6,018


$     6,797


Cost of goods sold


1,306


1,347


4,918


5,415


Gross profit


362


310


1,100


1,382


Operating (credits) expenses


(42)


259


618


954


Restructuring, impairment and plant closing costs (credits)


15


1


49


(41)


Operating income


389


50


433


469


Interest expense


(23)


(25)


(86)


(111)


Equity in income of investment in unconsolidated affiliates


17


13


42


54


Fair value adjustments to Venator investment and related loss on disposal


12


72


(88)


(18)


Loss on early extinguishment of debt


-


-


-


(23)


Other income, net


9


4


36


20


Income from continuing operations before income taxes


404


114


337


391


Income tax (expense) benefit


(37)


151


(46)


38


Income from continuing operations


367


265


291


429


(Loss) income from discontinued operations, net of tax(3)


(7)


43


775


169


Net income


360


308


1,066


598


Net income attributable to noncontrolling interests, net of tax


(17)


(5)


(32)


(36)


Net income attributable to Huntsman Corporation


$        343


$        303


$     1,034


$        562












Adjusted EBITDA(1)


$        240


$        182


$        647


$        846


Adjusted net income(1)


$        113


$          65


$        218


$        353












Basic income per share


$       1.56


$       1.35


$       4.69


$       2.46


Diluted income per share


$       1.54


$       1.34


$       4.66


$       2.44


Adjusted diluted income per share(1)


$       0.51


$       0.29


$       0.98


$       1.53












Common share information:










Basic weighted average shares


220


225


221


229


Diluted weighted average shares


222


227


222


231


Diluted shares for adjusted diluted income per share


222


227


222


231












See end of press release for footnote explanations.










 














Table 2 – Results of Operations by Segment




Three months ended




Twelve months ended





December 31,


Better /


December 31,


Better /

In millions


2020


2019


(Worse)


2020


2019


(Worse)














Segment Revenues:













Polyurethanes


$     1,030


$        980


5%


$     3,584


$     3,911


(8%)

Performance Products


265


278


(5%)


1,023


1,158


(12%)

Advanced Materials


207


241


(14%)


839


1,044


(20%)

Textile Effects


173


180


(4%)


597


763


(22%)

Corporate and Eliminations


(7)


(22)


n/m


(25)


(79)


n/m














Total


$     1,668


$     1,657


1%


$     6,018


$     6,797


(11%)














Segment Adjusted EBITDA(1):













Polyurethanes


$        201


$        122


65%


$        472


$        548


(14%)

Performance Products


41


43


(5%)


164


168


(2%)

Advanced Materials


27


42


(36%)


130


201


(35%)

Textile Effects


18


18


0%


42


84


(50%)

Corporate, LIFO and other


(47)


(43)


(9%)


(161)


(155)


(4%)














Total


$        240


$        182


32%


$        647


$        846


(24%)

n/m = not meaningful


























See end of press release for footnote explanations.











 













Table 3 – Factors Impacting Sales Revenue








Three months ended




December 31, 2020 vs. 2019




Average Selling Price(a)










Local


Exchange


Sales Mix


Sales






Currency


Rate


& Other


Volume(b)


Total














Polyurethanes


8%


3%


(3%)


(3%)


5%














Performance Products


(2%)


2%


(1%)


(4%)


(5%)














Advanced Materials


2%


1%


(4%)


(13%)


(14%)














Textile Effects


(6%)


0%


(1%)


3%


(4%)




























Twelve months ended




December 31, 2020 vs. 2019




Average Selling Price(a)










Local


Exchange


Sales Mix


Sales






Currency


Rate


& Other


Volume(b)


Total














Polyurethanes


(3%)


0%


0%


(5%)


(8%)














Performance Products


(4%)


0%


3%


(11%)


(12%)














Advanced Materials


2%


(1%)


(2%)


(19%)


(20%)














Textile Effects


(3%)


(1%)


(2%)


(16%)


(22%)


























(a) Excludes sales from tolling arrangements, by-products and raw materials.








(b) Excludes sales from by-products and raw materials.






















 

Table 4 – Reconciliation of U.S. GAAP to Non-GAAP Measures

































 Income Tax






 Diluted Income



 EBITDA


(Expense) Benefit


 Net Income


 Per Share



Three months ended


Three months ended


Three months ended


Three months ended



December 31,


December 31,


December 31,


December 31,

In millions, except per share amounts


2020


2019


2020


2019


2020


2019


2020


2019


















Net income


$        360


$        308






$        360


$        308


$       1.62


$       1.36

Net income attributable to noncontrolling interests


(17)


(5)






(17)


(5)


(0.08)


(0.02)


















Net income attributable to Huntsman Corporation


343


303






343


303


1.54


1.34

Interest expense from continuing operations


23


25













Income tax expense (benefit) from continuing operations


37


(151)


$         (37)


$        151









Income tax expense (benefit) from discontinued operations(3)


3


(9)













Depreciation and amortization from continuing operations


77


69













Depreciation and amortization from discontinued operations(3)


-


2













Business acquisition and integration expenses (income) and purchase accounting inventory adjustments


1


1


-


1


1


2


-


0.01

EBITDA / Loss (income) from discontinued operations, net of tax(3)


4


(36)


 N/A


 N/A


7


(43)


0.03


(0.19)

U.S. tax reform impact on tax expense


-


-


-


(4)


-


(4)


-


(0.02)

Significant activities related to deferred tax assets and liabilities(a)


-


-


-


(160)


-


(160)


-


(0.71)

(Gain) loss on sale of businesses/assets


(279)


21


31


(5)


(248)


16


(1.12)


0.07

Income from transition services arrangements


(1)


-


1


-


-


-


-


-

Fair value adjustments to Venator Investment and related loss on disposal(b)


(12)


(72)


(9)


-


(21)


(72)


(0.09)


(0.32)

Certain legal and other settlements and related expenses


3


5


(1)


(1)


2


4


0.01


0.02

Certain non-recurring information technology project implementation costs


3


3


(1)


(1)


2


2


0.01


0.01

Amortization of pension and postretirement actuarial losses


19


17


(5)


(3)


14


14


0.06


0.06

Restructuring, impairment and plant closing and transition costs


18


1


(6)


-


12


1


0.05


-

Plant incident remediation costs


1


3


-


(1)


1


2


-


0.01


















Adjusted(1)


$        240


$        182


$         (27)


$         (23)


$        113


$          65


$       0.51


$       0.29


















Adjusted income tax expense(1)










$          27


$          23





Net income attributable to noncontrolling interests, net of tax










17


5






















Adjusted pre-tax income(1)










$        157


$          93






















Adjusted effective tax rate(4)










17%


25%






















Effective tax rate










9%


n/m




























 Income Tax






 Diluted Income



 EBITDA


(Expense) Benefit


 Net Income


 Per Share



Twelve months ended


Twelve months ended


Twelve months ended


Twelve months ended



December 31,


December 31,


December 31,


December 31,

In millions, except per share amounts


2020


2019


2020


2019


2020


2019


2020


2019


















Net income


$      1,066


$        598






$      1,066


$        598


$       4.80


$       2.59

Net income attributable to noncontrolling interests


(32)


(36)






(32)


(36)


(0.14)


(0.16)


















Net income attributable to Huntsman Corporation


1,034


562






1,034


562


4.66


2.44

Interest expense from continuing operations


86


111













Income tax expense (benefit) from continuing operations


46


(38)


$         (46)


$          38









Income tax expense from discontinued operations(3)


242


35













Depreciation and amortization from continuing operations


283


270













Depreciation and amortization from discontinued operations(3)


-


61













Business acquisition and integration expenses and purchase accounting inventory adjustments


31


5


(6)


-


25


5


0.11


0.02

EBITDA / Income from discontinued operations, net of tax(3)


(1,017)


(265)


N/A


N/A


(775)


(169)


(3.49)


(0.73)

U.S. tax reform impact on tax expense


-


-


-


(1)


-


(1)


-


-

Significant activities related to deferred tax assets and liabilities(a)


-


-


-


(160)


-


(160)


-


(0.69)

Impact of Switzerland income tax rate change


-


-


-


32


-


32


-


0.14

(Gain) loss on sale of businesses/assets


(280)


21


31


(5)


(249)


16


(1.12)


0.07

Income from transition services arrangements


(7)


-


2


-


(5)


-


(0.02)


-

Fair value adjustments to Venator Investment and related loss on disposal(b)


88


18


(9)


-


79


18


0.36


0.08

Loss on early extinguishment of debt


-


23


-


(5)


-


18


-


0.08

Certain legal and other settlements and related expenses


5


6


(1)


(1)


4


5


0.02


0.02

Certain non-recurring information technology project implementation costs


6


4


(1)


(1)


5


3


0.02


0.01

Amortization of pension and postretirement actuarial losses


76


66


(17)


(16)


59


50


0.27


0.22

Restructuring, impairment and plant closing and transition costs (credits)


52


(41)


(13)


9


39


(32)


0.18


(0.14)

Plant incident remediation costs


2


8


-


(2)


2


6


0.01


0.03


















Adjusted(1)


$        647


$        846


$         (60)


$       (112)


$        218


$        353


$       0.98


$       1.53


















Adjusted income tax expense(1)










$          60


$        112





Net income attributable to noncontrolling interests, net of tax










32


36






















Adjusted pre-tax income(1)










$        310


$        501






















Adjusted effective tax rate(4)










19%


22%






















Effective tax rate










14%


(10%)























(a) During the year ended December 31, 2019, we recorded $153 million of tax benefit relating to the outside basis difference in our investment in Venator, we recorded $18 million of tax benefit relating to realized tax losses on our remaining interest in Venator, we established $11 million















     of significant income tax valuation allowance in Australia and we recorded $32 million of deferred tax expense due to the reduction of tax rates in Switzerland. During the year ended December 31, 2018, we released $119 million of significant income tax valuation allowances in















     Switzerland, the U.K. and Luxembourg. We eliminated the effect of these significant changes in tax valuation allowances and deferred tax assets and liabilities from our presentation of adjusted net income to allow investors to better compare our ongoing financial performance from















     period to period.

















(b) Represents the changes in market value in Huntsman's interest in Venator and related loss on disposal of Venator shares sold in December 2020.
































N/A = not applicable

















See end of press release for footnote explanations.

















        






Table 5 – Selected Balance Sheet Items








December 31,


December 31,

In millions


2020


2019






Cash


$            1,593


$               525

Accounts and notes receivable, net


910


953

Inventories


848


914

Other current assets


217


155

Current assets held for sale


-


1,208

Property, plant and equipment, net


2,505


2,383

Other noncurrent assets


2,640


2,182






Total assets


$            8,713


$            8,320






Accounts payable


$               876


$               822

Other current liabilities


510


462

Current portion of debt


593


212

Current liabilities held for sale


-


512

Long-term debt


1,528


2,177

Other noncurrent liabilities


1,533


1,311

Huntsman Corporation stockholders' equity


3,519


2,687

Noncontrolling interests in subsidiaries


154


137






Total liabilities and equity


$            8,713


$            8,320






 

Table 6 – Outstanding Debt













December 31,


December 31,

In millions


2020


2019






Debt:





Revolving credit facility


$                  -


$                 40

Accounts receivable programs


-


167

Term loan


-


103

Senior notes


2,047


1,963

Variable interest entities


50


65

Other debt


24


51






Total debt - excluding affiliates


2,121


2,389






Total cash


1,593


525






Net debt - excluding affiliates(5)


$               528


$            1,864






See end of press release for footnote explanations.










 

Table 7 – Summarized Statement of Cash Flows









Three months ended


Twelve months ended



December 31,


December 31,

In millions


2020


2019


2020


2019










Total cash at beginning of period


$         1,168


$            418


$            525


$            340










Net cash provided by operating activities from continuing operations


167


222


277


656

Net cash (used in) provided by operating activities from discontinued operations(3)


(2)


19


(24)


241

Net cash provided by (used in) investing activities from continuing operations


357


(90)


1,462


(201)

Net cash provided by (used in) investing activities from discontinued operations(3)


1


(28)


1


(59)

Net cash used in financing activities


(109)


(19)


(655)


(450)

Effect of exchange rate changes on cash


11


3


7


(2)










Total cash at end of period


$         1,593


$            525


$         1,593


$            525










Free cash flow from continuing operations(2):









Net cash provided by operating activities


$            167


$            222


$            277


$            656

Capital expenditures


(79)


(93)


(249)


(274)










Free cash flow from continuing operations


$              88


$            129


$              28


$            382










Taxes paid on sale of Chemical Intermediates and India-Based DIY Businesses


$              69


$                 -


$            257


$                 -










Adjusted free cash flow from continuing operations(6):


$            157


$            129


$            285


$            382










Supplemental cash flow information:









Cash paid for interest


$             (41)


$             (46)


$             (90)


$           (111)

Cash paid (received) for income taxes


(74)


2


(316)


(100)

Cash paid for restructuring and integration


(3)


(7)


(27)


(21)

Cash paid for pensions


(28)


(24)


(101)


(92)

Depreciation and amortization of continuing operations


77


69


283


270










Change in primary working capital:









Accounts and notes receivable


$              (3)


$              69


$            100


$            138

Inventories


(9)


58


145


77

Accounts payable


117


37


32


21

Total change in primary working capital


$            105


$            164


$            277


$            236










See end of press release for footnote explanations.


















Footnotes



(1)

We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance
of our business segments.  We provide adjusted net income because we feel it provides meaningful insight for the investment
community into the performance of our business.  We believe that net income (loss) is the performance measure calculated and
presented in accordance with generally accepted accounting principles in the U.S. ("GAAP") that is most directly comparable to
adjusted EBITDA and adjusted net income (loss).  Additional information with respect to our use of each of these financial measures follows:




Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily
comparable to other similarly titled measures of other companies.




Adjusted EBITDA is computed by eliminating the following from net income (loss):  (a) net income attributable to noncontrolling
interests, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization (e) amortization of pension and postretirement
actuarial losses (gains); (f) restructuring, impairment and plant closing costs (credits); and further adjusted for certain other items
set forth in reconciliation of adjusted EBITDA to net income (loss) in Table 4 above. 




Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the
following items from net income (loss): (a) net income attributable to noncontrolling interest; (b) amortization of pension
and postretirement actuarial losses (gains); (c) restructuring, impairment and plant closing costs (credits); and further adjusted for
certain other items set forth in reconciliation of adjusted EBITDA to net income (loss) in Table 4 above.  The income tax impacts, if
any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total
adjusted tax expense, computed without consideration of any adjusting items using a with and without approach.




We do not provide reconciliations for adjusted EBITDA, adjusted net income (loss) or adjusted diluted income (loss) per share on a
forward-looking basis because we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and
the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and
amount of certain items, such as, but not limited to, (a) business acquisition and integration expenses and purchase accounting
adjustments, (b) merger costs, and (c) certain legal and other settlements and related costs. Each of such adjustments has not yet
occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the
probable significance of the unavailable information. 



(2)

Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan
stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. We have historically defined free cash flow
as cash flows provided by operating activities and used in investing activities, excluding acquisition/disposition activities and
including non-recurring separation costs. Starting with the quarter ended March 31, 2020, we updated our definition of free cash
flow to a presentation more consistent with today's market standard of net cash provided by operating activities less capital
expenditures. Using our updated definition, our free cash flow for the years ended December 31, 2020, 2019, and 2018 were $28
million, $382 million, and $453 million, respectively. Free cash flow is not a defined term under U.S. GAAP, and it should not be
inferred that the entire free cash flow amount is available for discretionary expenditures.



(3)

During the third quarter 2019, we entered into an agreement to sell our Chemical Intermediates Businesses. Results from these
businesses, including the associated gain on sale, was treated as discontinued operations until the completion of the sale on
January 3, 2020.



(4)

We believe adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items that
management believes are not indicative of the businesses' operational profitability and that may obscure underlying business
results and trends. In our view, effective tax rate is the performance measure calculated and presented in accordance with U.S.
GAAP that is most directly comparable to adjusted effective tax rate.




The reconciliation of historical adjusted effective tax rate and effective tax rate is set forth in Table 4 above. We do not provide
reconciliations for adjusted effective tax rate on a forward-looking basis because we are unable to provide a meaningful or accurate
calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the
inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, (a) business acquisition and
integration expenses, (b) merger costs, and (c) certain legal and other settlements and related costs. Each of such adjustments
has not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to
address the probable significance of the unavailable information. 



(5)

Net debt is a measure we use to monitor how much debt we have after taking into account our total cash. We use it as an indicator
of our overall financial position, and calculate it by taking our total debt, including the current portion, and subtracting total cash. 



(6)

Adjusted free cash flow is defined as free cash flow, as described above, adjusted by excluding the taxes paid in connection with
the sale of our Chemical Intermediates Businesses and the sale of the India-based DIY business.  We believe that adjusted free
cash flow provides a useful comparison from period to period because it excludes the impact of cash taxes unrelated to our
operations. Additionally, the proceeds received from the sale of our Chemical Intermediates Businesses and the sale of the India-
based DIY business were classified as cash provided by investing activities and therefore was not factored into our free cash
flow.  As result, we believe the adjustment to exclude the taxes paid associated with this sale provides a meaningful measure of
our free cash flow.

About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2020 revenues of approximately $6 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 70 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 9,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at www.huntsman.comhttps://c212.net/c/link/?t=0&l=en&o=2729073-1&h=708906847&u=http%3A%2F%2Fwww.huntsman.com%2F&a=www.huntsman.com.

Social Media:
Twitter: www.twitter.com/Huntsman_Corp
Facebook: www.facebook.com/huntsmancorp
LinkedIn: www.linkedin.com/company/huntsman

Forward-Looking Statements:
Certain information in this release constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed under the caption "Risk Factors" in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman's operations, including any delay of, or other negative developments affecting the ability to implement cost reductions, timing of proposed transactions, and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.

 

SOURCE Huntsman Corporation

Loading...
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsCommoditiesPress Releaseschemical
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...